Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07160712 · ClinicalTrials.gov registry record · NA

Radicle Relief 24_RLN: A Study Assessing the Impact of Health and Wellness Products on Pain and Related Health Outcomes.

A NA study of Pain, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT07160712 is a NA study of Pain that has completed, run by Radicle Science. The registered enrollment target is 1,000 participants, above the 302-participant average among 374 other Pain trials with a reported enrollment target (231% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07160712, a NA study of Pain, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on pain and related health outcomes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Relief Product Placebo Control
  • DIETARY_SUPPLEMENT Relief Active Product 1
  • DIETARY_SUPPLEMENT Relief Active Product 2
  • DIETARY_SUPPLEMENT Relief Active Product 3

Study Locations (1)

California

  • Radicle Science Inc. - Del Mar

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-09-04
Est. Completion 2025-12-08
Phase NA

Sponsor

Radicle Science

55 total trials

What the Registry Record Tells You About NCT07160712

The ClinicalTrials.gov registry entry for NCT07160712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 302-participant average among 374 other Pain trials with a reported enrollment target (231% higher). The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Relief Product Placebo Control is the first listed.

NCT07160712 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07160712 about?

NCT07160712 is a clinical study titled "Radicle Relief 24_RLN: A Study Assessing the Impact of Health and Wellness Products on Pain and Related Health Outcomes.". A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on pain and related health outcomes.

What is the current status of trial NCT07160712?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-09-04. Estimated completion is 2025-12-08.

What conditions does trial NCT07160712 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT07160712?

The interventions under investigation include: Relief Product Placebo Control (DIETARY_SUPPLEMENT), Relief Active Product 1 (DIETARY_SUPPLEMENT), Relief Active Product 2 (DIETARY_SUPPLEMENT), Relief Active Product 3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07160712?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07160712 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.